The present invention concerns a method of treating chronic myelogenous leukemia, a related myeloproliferative disorder or a Ph-positive acute lymphocytic leukemia in a subject animal, comprising:

    • (a) selecting or identifying an animal suffering from chronic myelogenous leukemia or a related myeloproliferative disorder and showing resistance or intolerance to treatment with STI571; and
    • (b) administering to the animal homoharringtonine.
  • In a preferred embodiment, the animal is a human being.


    < Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof

    < Health supplement

    > Aripiprazole, olanzapine and haloperidol pamoate salts

    > Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones

    ~ 00232